A Study to Test the Effects of Different Tablet Formulations of PF-07104091 and Food on Blood Levels of PF-07104091 in Healthy Participants.  A Phase 1, Randomized, Open-Label, 4-Period, 5-Treatment, 6-Sequence, Crossover, Single-Dose Study in Healthy Participants to Investigate the Effect of Tablet Formulation and Food on the Bioavailability of PF-07104091.